Norwegian University of Science and Technology: Obesity, Morbid trials
The registry lists 33 Obesity, Morbid studies with Norwegian University of Science and Technology as lead sponsor. 21 are open to participants now and 0 have results posted.
Phase 2 1No phase 32(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Bariatric Surgery and Pharmacokinetics of ParacetamolRecruitingNCT03538457
- Bariatric Surgery and Pharmacokinetics of ValsartanRecruitingNCT03535376
- Bariatric Surgery and Pharmacokinetics of VenlafaxineRecruitingNCT03532477
- Bariatric Surgery and Pharmacokinetics of MetoprololRecruitingNCT03519906
- Bariatric Surgery and Pharmacokinetics of LosartanRecruitingNCT03519893
- Bariatric Surgery and Pharmacokinetics of LercanidipineRecruitingNCT03497156
- Bariatric Surgery and Pharmacokinetics of LamotrigineRecruitingNCT03497143
- Bariatric Surgery and Pharmacokinetics of IrbesartanRecruitingNCT03476603
- Bariatric Surgery and Pharmacokinetics of IbuprofenRecruitingNCT03476577
- Bariatric Surgery and Pharmacokinetics of HydrochlorothiazideRecruitingNCT03476551
- Bariatric Surgery and Pharmacokinetics of GabapentinRecruitingNCT03476538
- Bariatric Surgery and Pharmacokinetics of FluoxetineRecruitingNCT03476525
- Bariatric Surgery and Pharmacokinetics of EscitalopramRecruitingNCT03460379
- Bariatric Surgery and Pharmacokinetics of EnalaprilRecruitingNCT03460366
- Bariatric Surgery and Pharmacokinetics of CandesartanRecruitingNCT03460327
- Bariatric Surgery and Pharmacokinetics of BuprenorphineRecruitingNCT03460314
- Bariatric Surgery and Pharmacokinetics of ChlorprothixeneRecruitingNCT03449485
- Bariatric Surgery and Pharmacokinetics of QuetiapineRecruitingNCT03449472
- Bariatric Surgery and Pharmacokinetics of ApixabanRecruitingNCT03448783
- Bariatric Surgery and Pharmacokinetics of RamiprilRecruitingNCT03440177
- Bariatric Surgery and Pharmacokinetics of AmlodipineRecruitingNCT02904291
- Bariatric Surgery and Pharmacokinetics of LisdexamphetamineCompletedNCT03497169
- Bariatric Surgery and Pharmacokinetics of DexamphetamineCompletedNCT03460353
- Bariatric Surgery and Pharmacokinetics of AtomoxetineCompletedNCT03460210
- Bariatric Surgery and Pharmacokinetics of MethylphenidateCompletedNCT03440190
- Intragastric Injections of Botox for the Treatment of ObesityStatus unknownNCT02035397Phase 2
- BAR-trial: Bioavailability of Ethanol Following Bariatric SurgeryCompletedNCT01840020
- Weight Loss Maintenance and Compensatory Mechanisms Activated With a Very-low Calorie DietCompletedNCT01834859Not applicable
- Suboptimal Weight Loss After Gastric Bypass SurgeryTerminatedNCT01829906Not applicable
- Effect of Milk-free Diet on Weight and Irritable Bowel Syndrome in Morbid ObesityWithdrawnNCT01686919Not applicable
- Plantar Callosities and the Validity of Body Composition Assessment by Bio-impedance in Severely Obese PersonsCompletedNCT01676883Not applicable
- Effect of Exercise Before Gastric BypassCompletedNCT01042002Not applicable
- Morbid Obesity: Effects of Conservative Treatments and Gastric Bypass SurgeryCompletedNCT00239850Not applicable